Cargando…

Benefit of early discharge among patients with low-risk pulmonary embolism

Clinical guidelines recommend early discharge of patients with low-risk pulmonary embolism (LRPE). This study measured the overall impact of early discharge of LRPE patients on clinical outcomes and costs in the Veterans Health Administration population. Adult patients with ≥1 inpatient diagnosis fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Li, Baser, Onur, Wells, Phil, Peacock, W. Frank, Coleman, Craig I., Fermann, Gregory J., Schein, Jeff, Crivera, Concetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634547/ https://www.ncbi.nlm.nih.gov/pubmed/29016692 http://dx.doi.org/10.1371/journal.pone.0185022

Ejemplares similares

Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary Embolism
por: Wang, Li, et al.
Publicado: (2019)

Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care
por: Peacock, W. Frank, et al.
Publicado: (2019)

External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches
por: Weeda, Erin R., et al.
Publicado: (2016)

External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications
por: Coleman, Craig I., et al.
Publicado: (2016)

Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis
por: Nguyen, Elaine, et al.
Publicado: (2017)

Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database
por: Coleman, Craig I, et al.
Publicado: (2015)

Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed
por: Crivera, Concetta, et al.
Publicado: (2016)

Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome
por: Chen, Shih-Yin, et al.
Publicado: (2014)

Treatment of Pulmonary Embolism With Rivaroxaban: Outcomes by Simplified Pulmonary Embolism Severity Index Score from a Post Hoc Analysis of the EINSTEIN PE Study
por: Fermann, Gregory J, et al.
Publicado: (2015)

Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge
por: Wang, Li, et al.
Publicado: (2011)

Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population
por: Chen, Shih-Yin, et al.
Publicado: (2013)

Emergency Department Discharge of Pulmonary Embolus Patients
por: Frank Peacock, W., et al.
Publicado: (2018)

Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study
por: Zhao, Qi, et al.
Publicado: (2019)

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
por: Margolis, Jay M., et al.
Publicado: (2016)

Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism
por: Berger, Jeffrey S., et al.
Publicado: (2017)

Discharge or admit? Emergency department management of incidental pulmonary embolism in patients with cancer: a retrospective study
por: Banala, Srinivas R., et al.
Publicado: (2017)

External validation of the modified HOPPE score to predict low risk pulmonary embolism suitable for early discharge
por: Patel, Kajal, et al.
Publicado: (2020)

Reducing the hospital burden associated with the treatment of pulmonary embolism
por: Peacock, W. Frank, et al.
Publicado: (2019)

Duration of anticoagulant therapy and VTE recurrence in patients with cancer
por: Khorana, Alok A., et al.
Publicado: (2019)

Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis
por: Khorana, Alok A., et al.
Publicado: (2017)

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
por: Nelson, Winnie W., et al.
Publicado: (2014)

Admission rates for emergency department patients with venous thromboembolism and estimation of the proportion of low risk pulmonary embolism patients: a US perspective
por: Singer, Adam J., et al.
Publicado: (2016)

Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer
por: Streiff, Michael B., et al.
Publicado: (2018)

The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation
por: Khorana, Alok A., et al.
Publicado: (2018)

New Prospective for the Management of Low-Risk Pulmonary Embolism: Prognostic Assessment, Early Discharge, and Single-Drug Therapy with New Oral Anticoagulants
por: Squizzato, Alessandro
Publicado: (2012)

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
por: Laliberté, François, et al.
Publicado: (2015)

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
por: Laliberté, François, et al.
Publicado: (2015)

Timing of Discharge Follow-up for Acute Pulmonary Embolism: Retrospective Cohort Study
por: Vinson, David R., et al.
Publicado: (2015)

Bilateral Pulmonary Embolism in a Discharged Patient With Resolved COVID-19 Pneumonia
por: Koche, Mrunal, et al.
Publicado: (2020)

Pulmonary embolism after discharge for COVID-19: A report of two cases
por: Deutch, Mikkel Rodin, et al.
Publicado: (2021)

Predicting in-hospital death during acute presentation with pulmonary embolism to facilitate early discharge and outpatient management
por: Lau, Jerrett K., et al.
Publicado: (2017)

Recurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis
por: Lang, Kathleen, et al.
Publicado: (2014)

Correlates of In-Hospital Deaths among Hospitalizations with Pulmonary Embolism: Findings from the 2001−2008 National Hospital Discharge Survey
por: Tsai, James, et al.
Publicado: (2012)

Low-dose thrombolysis for submassive pulmonary embolism
por: Yilmaz, Emine Serap, et al.
Publicado: (2021)

The Diagnostic Role of Adiponectin in Pulmonary Embolism
por: Gul, Evrim, et al.
Publicado: (2016)

Safety of early orthopedic surgery in patients with intermediate/low- or low-risk pulmonary embolism
por: Kim, Ho Cheol, et al.
Publicado: (2020)

PULMONARY EMBOLISM : AN EXPERIMENTAL STUDY.
por: Mann, Frank C.
Publicado: (1917)

Applying State-of-the-Art Survival Extrapolation Techniques to the Evaluation of CAR-T Therapies: Evidence from a Systematic Literature Review
por: Sussman, Matthew, et al.
Publicado: (2021)

Population density index and its use for distribution of Covid-19: A case study using Turkish data
por: Baser, Onur
Publicado: (2021)

Generalized Propensity Score Matching with Multilevel Treatment Options
por: Baser, Onur
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_69u6btvq94nlcnaisugo22b1e8